Mereo BioPharma (MREO) Current Assets (2017 - 2026)
Mereo BioPharma (MREO) recorded Current Assets of $33.4 million in Q2 2026, down 45.6% from $61.42 million a year earlier and down 16.6% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma reported Current Assets of $45.02 million, down 39.8% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $74.76 million in FY2024 (+17.3%), $63.76 million in FY2023 (-15.2%), $75.2 million in FY2022 (-43.8%) and $133.89 million in FY2021 (+241.1%).
- The Q2 2026 figure is the lowest quarterly Current Assets in data going back to Q4 2017.
- On a year-over-year basis, Current Assets has declined for five consecutive quarters, with an average decline of 22.5% over the last seven quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 241.1% in Q4 2021, against a decline of 45.6% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $40.03 million (Q1 2026), $45.02 million (Q4 2025) and $52.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Mereo BioPharma | 46.45 Mn | -103.46 Mn | - | 33.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.40 Mn |
| Mar 31, 2026 | 40.03 Mn |
| Dec 31, 2025 | 45.02 Mn |
| Sep 30, 2025 | 52.41 Mn |
| Jun 30, 2025 | 61.42 Mn |
| Mar 31, 2025 | 66.90 Mn |
| Dec 31, 2024 | 74.76 Mn |
| Sep 30, 2024 | 86.72 Mn |
| Jun 30, 2024 | 93.94 Mn |
| Mar 31, 2024 | 53.50 Mn |
| Dec 31, 2023 | 63.76 Mn |
| Jun 30, 2023 | 68.41 Mn |
| Dec 31, 2022 | 74.91 Mn |
| Jun 30, 2022 | 99.25 Mn |
| Dec 31, 2021 | 134.07 Mn |
| Jun 30, 2021 | 166.58 Mn |
| Dec 31, 2020 | 40.52 Mn |
| Jun 30, 2020 | 82.09 Mn |
| Dec 31, 2019 | 39.91 Mn |
| Jun 30, 2019 | 61.97 Mn |
API Access
Mereo BioPharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();